Examiner: MARVICH, MARIA

Tech Center 1600 • Art Units: 1631 1633 1634 1645

This examiner grants 55% of resolved cases

Performance Statistics

54.7%

Allow Rate

-5.3% vs TC avg

1,031

Total Applications

+28.1%

Interview Lift

1469

Avg Prosecution Days

Based on 984 resolved cases, 2023–2026

3.8%

§101 Eligibility

19.0%

§102 Novelty

27.6%

§103 Obviousness

35.8%

§112 Clarity

App #	Title	Status	Assignee
17932633	Modified EC7 Cells Having Low Toxicity to Viral Production Payloads	Non-Final OA	NantBio, Inc.
17767970	CANINE DISTEMPER VIRUS HEMAGGLUTININ AND FUSION POLYPEPTIDES	Final Rejection	Mayo Foundation for Medical Education and Research
17353587	METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS	Final Rejection	Board of Regents of The University of Texas System

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.